Vanda Pharmaceuticals Inc.
USE OF TRADIPITANT IN MOTION SICKNESS
Last updated:
Abstract:
Disclosed herein is a method of treating or preventing motion sickness or at least one symptom thereof, comprising treatment with the NK-1 receptor antagonist, tradipitant.
Status:
Application
Type:
Utility
Filling date:
28 Apr 2022
Issue date:
11 Aug 2022